Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
The Progressive Corporation reported financial results for the month ended August 31, 2026, with net income of $951 million ($1.63 per share) on net premiums earned of $7.35 billion. The company's combined ratio for the month was 89.3, and total policies in force grew 7% year-over-year to 40.5 million.
Smith Micro Software announced that its founder, William W. Smith, Jr., has returned as President and CEO, succeeding Timothy C. Huffmyer who resigned to pursue other opportunities. Mr. Smith previously led the company for over 40 years and had been serving as Executive Chairman since March 2026. Mr. Huffmyer will remain on the company's Board of Directors.
Karman Holdings Director David Stinnett Buys $1.01M of Stock
David Stinnett, Director, bought 27,000 shares of Karman Holdings Inc. at $37.32 a share, worth $1.01M in total on Sep 16, 2026. Shares held after the trade: 3,530,395 (+0.8%).
Karman Holdings Director Mary D. Petryszyn Buys $18.7K of Stock
Mary D. Petryszyn, Director, bought 500 shares of Karman Holdings Inc. at $37.44 a share, worth $18.7K in total on Sep 16, 2026. Shares held after the trade: 2,863 (+21.2%).
Karman Holdings Director Stephen Twitty Buys $10.1K of Stock
Stephen Twitty, Director, bought 275 shares of Karman Holdings Inc. at $36.79 a share, worth $10.1K in total on Sep 16, 2026. Shares held after the trade: 2,638 (+11.6%).
Halozyme Therapeutics priced an upsized private offering of $1.3 billion in 1.50% convertible senior notes due 2033, with an additional $200 million option granted to initial purchasers. The company entered into capped call transactions to manage potential dilution, with an initial cap price representing a 90% premium over the current stock price. Proceeds are intended for general corporate purposes, which may include debt repayment or share repurchases.
VisionWave Holdings, Inc. is implementing a 1-for-20 reverse stock split of its common stock, effective September 22, 2026. The split is intended to increase the per-share trading price to maintain compliance with Nasdaq's $1.00 minimum bid price requirement. The action will reduce the outstanding share count from approximately 47.5 million to 2.4 million shares.
Philip Morris International's Board of Directors declared a quarterly dividend of $1.60 per share, representing an 8.8% increase from the previous $1.47 per share. The dividend is payable on October 26, 2026, to shareholders of record as of October 2, 2026, bringing the annualized rate to $6.40 per share.
The Zcash ETF announced a 3-for-1 forward share split for shareholders of record as of September 28, 2026. The split will be payable on September 29, 2026, and shares will begin trading on a split-adjusted basis on September 30, 2026. The action will triple the number of outstanding shares and reduce the price per share by approximately two-thirds without changing the total value of shareholder investments.
PMGC Holdings and its subsidiary NorthStrive Biosciences entered into a binding payment agreement with Longevity Health Holdings to secure royalty payments from the 2025 sale of the Elevai Skincare business. The agreement converts a 5% net sales royalty into scheduled monthly cash payments through August 2031, including interest and mandatory prepayments tied to future capital events. This restructuring provides PMGC with visible, non-dilutive cash flow while allowing it to focus on its core manufacturing and defense technology segments.
Truist Financial President & CEO Michael P. Lyons Buys $1.02M of Stock
Michael P. Lyons, President & CEO, bought 21,000 shares of Truist Financial Corp at $48.36 a share, worth $1.02M in total on Sep 17, 2026. Shares held after the trade: 21,000.
Beneficient announced the upcoming launch of AltLens, a technology-enabled alternative asset portfolio analytics and risk platform designed for family offices and small institutional investors. The platform, scheduled to go live in Q4 2026, provides institutional-level risk modeling, stress-testing, and allocation analysis based on historical private market data. This launch aims to capture growing demand for sophisticated oversight tools as global alternative assets under management are projected to reach $29 trillion by 2029.
Scorpio Tankers Secretary Auste Adelborg Sells $613K of Stock
Auste Adelborg, Secretary, sold 6,834 shares of Scorpio Tankers Inc. at $89.64 a share, worth $613K in total on Sep 17, 2026. Shares held after the trade: 0 (-100.0%).
Ready Capital $225M Debt Financing with UMB Bank, N.A.
Ready Capital's subsidiary priced a private placement of $225 million in 10.00% Senior Secured Notes due 2031. The proceeds will be used to redeem $350 million of existing 4.50% Senior Secured Notes due 2026, marking a significant milestone in the company's balance sheet repositioning and deleveraging plan.
Or Offer, CEO, sold 76,119 shares of Similarweb Ltd. at $8.35 to $8.40 a share (average $8.38) in 2 transactions, worth $638K in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 4,177,381 (-0.7%).
Wenbin Qiu, CEO, bought 14,400 shares of Baozun Inc. at $2.74 to $2.84 a share (average $2.79) in 2 transactions, worth $40.2K in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 1,652,872 (+0.4%).
David Meleh Aviv, CTO, sold 15,000 shares of Radware Ltd at $30.71 a share, worth $461K in total on Sep 17, 2026. Shares held after the trade: 134,487 (-10.0%).
BlossomHill Therapeutics reported financial results for the second quarter of 2026, highlighting the successful completion of its $168.3 million IPO in August. The company also noted clinical progress for BH-30643, which received FDA Fast Track designation for the treatment of advanced EGFR C797S-positive NSCLC.
Term
Q2 2026
“We’ve achieved meaningful progress across our pipeline, as well as our significant corporate milestones, since the beginning of the second quarter. In April, we presented our first preclinical data from our pseudo-irreversible pan-KRAS inhibitor BH-501284, built on a novel chemical scaffold, at AACR where we highlighted the sustained target engagement leading to tumor regression at low dose levels.”
Jean Cui, Ph.D., Founder, President and Chief Executive Officer
“With a strong balance sheet following our successful initial public offering in August, we believe we are well positioned to deliver important clinical and regulatory milestones over the coming quarters as we continue advancing our intentionally designed medicines that address significant unmet medical needs in cancer treatment.”
Jean Cui, Ph.D., Founder, President and Chief Executive Officer
Roivant Sciences Ltd. held its 2026 Annual General Meeting of Shareholders on September 16, 2026, where shareholders approved all three agenda proposals. Key outcomes included the re-election of Daniel Gold and Meghan FitzGerald as Class II directors, the ratification of Ernst & Young LLP as the independent auditor, and the advisory approval of executive compensation.
CAVA Group's Board of Directors has authorized a new share repurchase program to buy back up to $100 million of its common stock. The program is set to expire on September 17, 2027, and will be funded through existing cash and operational cash flows.
Sunshine Silver Mining & Refining Other 8-K Filing
Sunshine Silver Mining & Refining Company announced its inclusion in the VanEck Junior Gold Miners ETF (GDXJ), effective September 18, 2026. The inclusion occurs three months after the company's IPO and is expected to increase investor visibility and trading liquidity. Management remains focused on returning the Sunshine Mine to production by late 2028.
Pentair plc appointed Louis V. Pinkham to its Board of Directors and the Audit and Finance Committee, effective September 17, 2026. Mr. Pinkham is classified as an independent director and will receive the company's standard non-employee director compensation.
Nova Minerals Corp filed a formal corporate presentation dated September 18, 2026, as an exhibit to its 8-K. The presentation provides a strategic update on the company's operations and was also made available on its corporate website.
Adient plc announced that Peter H. Carlin will resign from the board of directors to join the company as Vice President, Finance on October 1, 2026, before being appointed Executive Vice President and CFO on November 16, 2026. He succeeds Mark A. Oswald, whose departure was previously announced. Carlin's compensation package includes an $820,000 base salary and a $4.25 million target equity award for fiscal 2027.
Paradium.AI entered into a 10-year strategic platform agreement with RTB Digital (Roundtable) to form a strategic operating relationship where Roundtable will provide technology and monetization services for Paradium's media brands. Alongside the partnership, Roundtable is acquiring a 49.5% minority stake in Paradium.AI from an existing shareholder at $3.80 per share, though Paradium.AI remains an independent entity and will receive Roundtable stock in exchange for a technology license.
Evolution Metals & Technologies $30.9M Debt Financing with Ya II Pn, Ltd.
Evolution Metals & Technologies Corp. entered into a securities purchase agreement with Yorkville for the issuance of convertible debentures in the aggregate principal amount of approximately $30.9 million. The financing consists of an initial $22 million tranche issued immediately, with subsequent tranches totaling approximately $8.9 million contingent on the filing and effectiveness of a registration statement. The debentures bear 4% annual interest and mature in September 2028.
Artificial Intelligence Technology Solutions Wins Contract from A major public research university
AITX's subsidiary, Robotic Assistance Devices (RAD), received an order for seven RIO 360 solar-powered security systems for a major public research university. The university, which serves over 25,000 students, indicated that this initial deployment could lead to several additional orders to complete their total intended security rollout.
Viant Technology Inc. and a selling stockholder have terminated a previously announced underwritten public offering of 8,500,000 shares of Class A common stock. The decision to withdraw the offering was attributed to unfavorable market conditions, and no shares were sold under the program.
Diversified Energy M&A Deal with Camino Natural Resources, LLC
Diversified Energy Company filed an amendment to its July 6, 2026, 8-K to provide required audited and pro forma financial statements regarding its completed acquisition of certain affiliates of Camino Natural Resources, LLC. The acquisition included 100% of the equity interests in assets located in Oklahoma, including oil and natural gas wells, leasehold interests, and undeveloped acreage.